Meeting the challenge of depression in HIV.
Rabkin
J G
JG
Columbia University, College of Physicians and Surgeons, New York, NY.
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D003863:Depression / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D004347:Drug Interactions; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000523:psychology; D017320:HIV Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D015995:Prevalence; D013739:Testosterone / Q000627:therapeutic use; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D000928:Antidepressive Agents; D017320:HIV Protease Inhibitors; D013739:Testosterone